{
  "id": "clinical#general_9af55c13",
  "content": "Table 6.16. contd\nSubstance\nSubstance-specific features of withdrawal\nSynthetic Presenting features of synthetic cannabinoid withdrawal may include irritability,\ncannabinoids anger, aggression, shakiness, insomnia and disturbing dreams, restlessness, anxiety,\ndepressed or dysphoric mood and appetite disturbance. In the early phase, synthetic\ncannabinoid withdrawal may be accompanied by residual features of intoxication from\nthe drug, such as paranoid ideation and auditory and visual hallucinations.\nAdditional features\n• The occurrence, severity and duration of synthetic cannabinoid withdrawal vary\naccording to the type and potency of the synthetic cannabinoid used, as well as the\namount, frequency and duration of use before cessation or reduction of use.\n• Synthetic cannabinoid withdrawal typically lasts for 1–3 weeks after cessation\nof use.\nOpioids Presenting features of opioid withdrawal may include depressed or dysphoric mood,\ncraving for an opioid, anxiety, nausea or vomiting, abdominal cramps, muscle aches,\nyawning, perspiration, hot and cold flushes, hypersomnia (typically in the initial phase)\nor insomnia, diarrhoea, piloerection and pupillary dilation.\nAdditional features\n• The severity and time course of opioid withdrawal is influenced by many factors\nthat include the type of opioid taken, its half-life and duration of action, the amount,",
  "metadata": {
    "source": "WHO ICD-11",
    "url": "https://icd.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "sleep",
      "emotions"
    ],
    "is_clinical": false,
    "is_advice": false
  },
  "index_text": "General — General Table 6.16. contd\nSubstance\nSubstance-specific features of withdrawal\nSynthetic Presenting features of synthetic cannabinoid withdrawal may include irritability,\ncannabinoids anger, aggression, shakiness, insomnia and disturbing dreams, restlessness, anxiety,\ndepressed or dysphoric mood and appetite disturbance. In the early phase, synthetic\ncannabinoid withdrawal may be accompanied by residual features of intoxication from\nthe drug, such as paranoid ideation and auditory and visual hallucinations.\nAdditional features\n• The occurrence, severity and duration of synthetic cannabinoid withdrawal vary\naccording to the type and potency of the synthetic cannabinoid used, as well as the\namount, frequency and duration of use before cessation or reduction of use.\n• Synthetic cannabinoid withdrawal typically lasts for 1–3 weeks after cessation\nof use.\nOpioids Presenting features of opioid withdrawal may include depressed or dysphoric mood,\ncraving for an opioid, anxiety, nausea or vomiting, abdominal cramps, muscle aches,\nyawning, perspiration, hot and cold flushes, hypersomnia (typically in the initial phase)\nor insomnia, diarrhoea, piloerection and pupillary dilation.\nAdditional features\n• The severity and time course of opioid withdrawal is influenced by many factors\nthat include the type of opioid taken, its half-life and duration of action, the amount, Table 6.16. contd\nsubstance\nsubstance-specific features of withdrawal\nsynthetic presenting features of synthetic cannabinoid withdrawal may include irritability,\ncannabinoids anger, aggression, shakiness, insomnia and di..."
}